How should investors evaluate Azitra Inc (AMEX:AZTR)?

In yesterday’s Wall Street session, Azitra Inc (AMEX:AZTR) shares traded at $0.19, down -5.89% from the previous session.

AZTR stock price is now -10.98% away from the 50-day moving average and -83.16% away from the 200-day moving average. The market capitalization of the company currently stands at $5.48M.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

In other news, Staskey Norm, Chief Financial Officer bought 47,600 shares of the company’s stock on Mar 29 ’24. The stock was bought for $10,034 at an average price of $0.21. Upon completion of the transaction, the Chief Financial Officer now directly owns 51,100 shares in the company, valued at $9709.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 13 ’24, President and CEO Salva Francisco D. bought 333,300 shares of the business’s stock. A total of $99,990 was incurred on buying the stock at an average price of $0.30. This leaves the insider owning 338,300 shares of the company worth $64277.0. A total of 44.22% of the company’s stock is owned by insiders.

During the past 12 months, Azitra Inc has had a low of $0.16 and a high of $5.18. As of last week, the company has a debt-to-equity ratio of 0.19, a current ratio of 2.80, and a quick ratio of 2.80. The fifty day moving average price for AZTR is $0.21274 and a two-hundred day moving average price translates $1.07688 for the stock.

The latest earnings results from Azitra Inc (AMEX: AZTR) was released for 2023-12-31. According to the Biotechnology Company, earnings per share came in at -0.35, missing analysts’ expectations of -0.18 by -0.17. This compares to -$2.33 EPS in the same period last year. The net profit margin was -2165.66% and return on equity was -5059.78% for AZTR.

Related Posts